Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.

RTHM-014032021Meinhardt, Marcus W; Pfarr, Simone; Fouquet, Grégory; Rohleder, Cathrin; Meinhardt, Manuela L; Barroso-Flores, Janet; Hoffmann, Rebecca; Jeanblanc, Jérôme; Paul, Elisabeth; Wagner, Konstantin; Hansson, Anita C; Köhr, Georg; Meier, Nils; von Bohlen Und Halbach, Oliver; Bell, Richard L; Endepols, Heike; Neumaier, Bernd; Schönig, Kai; Bartsch, Dusan; Naassila, Mickaël; Spanagel, Rainer; Sommer, Wolfgang H

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.

Science advances, 7(47), eabh2399

View on PubMed ↗Publisher’s paper ↗

Citation

Meinhardt, Marcus W; Pfarr, Simone; Fouquet, Grégory; Rohleder, Cathrin; Meinhardt, Manuela L; Barroso-Flores, Janet; Hoffmann, Rebecca; Jeanblanc, Jérôme; Paul, Elisabeth; Wagner, Konstantin; Hansson, Anita C; Köhr, Georg; Meier, Nils; von Bohlen Und Halbach, Oliver; Bell, Richard L; Endepols, Heike; Neumaier, Bernd; Schönig, Kai; Bartsch, Dusan; Naassila, Mickaël; Spanagel, Rainer; Sommer, Wolfgang H. (2021). Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.. Science advances, 7(47), eabh2399. https://doi.org/10.1126/sciadv.abh2399